Deficiency of Phospholipase A2 Receptor Exacerbates Autoimmune Myocarditis in Mice
- 3 February 2020
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 43 (3) , 1097-1109
Abstract
Secretory phospholipase A2 (sPLA2) plays a critical role in the pathogenesis of various inflammatory diseases through production of pro-inflammatory eicosanoids. PLA2 receptor 1 (PLA2R) acts as a clearance receptor for sPLA2s. This study examined whether PLA2R plays a role in the pathogenesis of experimental autoimmune myocarditis using PLA2R-deficient (PLA2R KO) mice on a BALB/c background. Autoimmune myocarditis was induced by immunization with murine α-myosin heavy chain. In the immunostaining of PLA2R wild-type (WT) myocardium, PLA2R and sPLA2s were expressed in α-SMA+ cells and neutrophils, respectively. In immunoblot analyses, tissue from PLA2R KO myocardium after immunization had five to tenfold increases in the protein level of sPLA2-IB and sPLA2-IIA compared with PLA2R WT myocardium. However, the mRNA expression levels of these sPLA2s were similar in PLA2R KO and WT myocardium. Compared with PLA2R WT myocardium, PLA2R KO myocardium after immunization showed 40% increase in areas affected by infiltration of inflammatory cells, eight to tenfold increase in levels of PGE2 and TXB2, and a threefold increase in number of Th17 cells in heart infiltrates assessed by flow cytometric analysis. Finally, PGE2 promoted IL-23-induced expansion of Th17 cells in vitro. In conclusion, PLA2R-deficiency increased sPLA2-IB and sPLA2-IIA levels in the myocardium after immunization probably through impaired clearance, leading to increased levels of PGE2 in the myocardium. Elevated PGE2 induced Th17 cell expansion, exacerbating myocarditis in PLA2R KO mice. Thus, PLA2R plays an important role in pathogenesis of experimental autoimmune myocarditis.Keywords
Funding Information
- Japan Society for the Promotion of Science (B-22390158)
- AMED-CREST (JP17gm0710006)
This publication has 37 references indexed in Scilit:
- Disruption of group IVA cytosolic phospholipase A2attenuates myocardial ischemia-reperfusion injury partly through inhibition of TNF-α-mediated pathwayAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Regulation of Immune Responses by Prostaglandin E2The Journal of Immunology, 2012
- Prostaglandin E2and T cells: friends or foes?Immunology & Cell Biology, 2011
- The Anti-Inflammatory Mechanism of Prostaglandin E2 Receptor 4 Activation in Rat Experimental Autoimmune MyocarditisJournal of Cardiovascular Pharmacology, 2011
- The leukotriene B4 receptor, BLT1, is required for the induction of experimental autoimmune encephalomyelitisBiochemical and Biophysical Research Communications, 2010
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signalingJournal of Experimental Medicine, 2009
- TH17 cells in development: an updated view of their molecular identity and genetic programmingNature Reviews Immunology, 2008
- Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunityAutoimmunity, 2008